Caribou Biosciences is a biotechnology company that researches and develops gene-edited cell therapies for the treatment of cancer.
Business Model:
Revenue: $10.7M
Employees: 51-200
Address: 2929 7th Street
City: Berkeley
State: CA
Zip: 94710
Country: US
Caribou Biosciences is a biotechnology company that researches and develops gene-edited cell therapies for the treatment of cancer.
Contact Phone:
+15109826030
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/23/2021
IPO Valuation:
$907M
Ticker Symbol:
CRBU
IPO Price:
$16/share
Amount Raised:
$304M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2014 | Intellia Therapeutics | Series A | 0 |
11/2014 | Intellia Therapeutics | Series A | 0 |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|